New guidelines have been produced for the management of primary biliary cholangitis, an infrequent but nonetheless important autoimmune liver disease. We provide a succient commentary and overview of the key features of disease management that arise from these recent guideline recommendations, with a focus on therapy with licensed agents (ursodeoxycholic acid and obeticholic acid) as well as personalised management of disease complications and associated symptoms.

Additional Metadata
Persistent URL,
Journal Frontline Gastroenterology
Goet, J.C., & Hirschfield, G.M. (2019). Guideline review: British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis treatment and management guidelines. Frontline Gastroenterology, 10(3), 316–319. doi:10.1136/flgastro-2018-101109